| Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study V Periša, L Zibar, J Sinčić-Petričević, A Knezović, I Periša, J Barbić Croatian medical journal 56 (4), 334-343, 2015 | 77 | 2015 |
| Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma V Periša, L Zibar, A Knezović, I Periša, J Sinčić-Petričević, I Aurer Wiener klinische Wochenschrift 129, 411-419, 2017 | 29 | 2017 |
| Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis M Lucijanic, D Galusic, I Krecak, M Sedinic, H Holik, V Perisa, ... Annals of hematology 99, 2779-2785, 2020 | 28 | 2020 |
| Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis M Lucijanić, I Krečak, E Sorić, A Sabljic, D Galušić, H Holik, V Periša, ... Leukemia research 119, 2022 | 13 | 2022 |
| Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis M Lucijanic, I Krecak, D Galusic, M Sedinic, H Holik, V Perisa, ... Wiener klinische Wochenschrift, 1-7, 2021 | 12 | 2021 |
| Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis M Lucijanic, I Krecak, E Soric, A Sabljic, D Galusic, H Holik, V Perisa, ... Biochemia medica 33 (2), 2023 | 10 | 2023 |
| Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis M Lucijanic, I Krecak, S Verstovsek, E Soric, D Galusic, H Holik, V Perisa, ... Annals of hematology 101 (6), 1355-1357, 2022 | 9 | 2022 |
| Comparison of the prognostic impact of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and glasgow prognostic score in diffuse large B-cell lymphoma V Periša, A Knezović, L Zibar, J Sinčić-Petričević, D Mjeda, I Periša, ... Shiraz E-Medical Journal 17 (7), 1-11, 2016 | 9 | 2016 |
| Therapeutic dilemmas in the treatment of acute coronary syndrome as manifestation of essential thrombocythaemia I Bošnjak, K Selthofer-Relatić, V Periša, R Steiner Journal of cardiology cases 8 (5), 168-171, 2013 | 7 | 2013 |
| C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis M Lucijanic, D Galusic, I Krecak, M Sedinic, E Soric, H Holik, V Perisa, ... Leukemia & lymphoma 61 (12), 2969-2974, 2020 | 5 | 2020 |
| Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms I Krečak, D Grohovac, NV Bašić, M Čeko, K Nižetić, A Sabljić, H Holik, ... Thrombosis research 231, 141-143, 2023 | 4 | 2023 |
| Non-myelofibrosis chronic myeloproliferative neoplasm patients show better seroconversion rates after SARS-CoV-2 vaccination compared to other hematologic diseases: a … Z Sertić, M Lucijanić, S Bašić-Kinda, R Serventi Seiwerth, V Periša, ... Biomedicines 10 (11), 2892, 2022 | 4 | 2022 |
| Patterns of the physical, cognitive, and mental health status of older individuals in a real-life primary care setting and differences in coping styles T Wittlinger, S Bekić, S Guljaš, V Periša, M Volarić, L Trtica Majnarić Frontiers in medicine 9, 989814, 2022 | 3 | 2022 |
| High plateletcrit may be associated with thrombotic risk in polycythemia vera I Krečak, I Zekanović, M Morić Perić, H Holik, B Coha, V Periša, ... International journal of laboratory hematology 45 (5), 799-801, 2023 | 2 | 2023 |
| MPN-541 estimated plasma volume status in patients with primary myelofibrosis and Associated Thrombotic and Mortality Risks M Lucijanic, I Krecak, E Soric, A Sabljic, D Galusic, H Holik, V Perisa, ... Clinical Lymphoma Myeloma and Leukemia 22, S341-S342, 2022 | 2 | 2022 |
| Perindopril/amlodipine-induced thrombotic microangiopathy V Periša, D Laslo, L Maričić, L Zibar Turkish Journal of Emergency Medicine 21 (1), 38-41, 2021 | 2 | 2021 |
| Triple A score (AAA: Age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis M Lucijanic, I Krecak, D Galusic, H Holik, V Perisa, M Moric Peric, ... Annals of hematology 103 (6), 2157-2159, 2024 | 1 | 2024 |
| Atrial Fibrillation in Patients with Myelofibrosis M Lucijanic, I Krecak, E Soric, A Sabljic, D Galusic, H Holik, V Perisa, ... Blood 142, 6437, 2023 | 1 | 2023 |
| P1040: higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival IN patients with primary myelofibrosis M Lucijanic, I Krecak, E Soric, D Galusic, H Holik, V Perisa, MM Peric, ... HemaSphere 6, 930-931, 2022 | 1 | 2022 |
| Serologic responses following Sars-Cov-2 vaccination and factors influencing it in patients with hematological malignant and non-malignant diseases-a prospective multicentric study Z Sertić, M Lucijanic, S Bašić-Kinda, RS Seiwerth, V Periša, D Sertić, ... Blood 138, 47, 2021 | 1 | 2021 |
